Raymond James reiterates QXO stock rating on earnings beat
Raymond James reiterated an Outperform rating and $21.00 price target for QXO Inc (NASDAQ:QXO), citing strong Q3 EBITDA and encouraging Q4 trends. The stock trades at $12.60, with management projecting double-digit organic sales growth and 20-25% incremental margins through 2030. Other analysts have adjusted price targets, with DA Davidson and Truist Securities maintaining Buy ratings but lowering targets to $19 and $15, respectively, due to operating costs and market conditions.
How this was made
The 30-second read
Why it matters
For traders, the main incremental signal is the reiterated Outperform stance with a $21 target, plus the mention that options positioning implies a potential earnings-driven move, though timing is not confirmed.
Market read
Single-name analyst reiteration with a valuation narrative; useful for sentiment and positioning but not a new fundamental disclosure.
What to watch
The piece relies on valuation assumptions (EV/EBITDA multiple, growth and margin scenarios) rather than new guidance; traders may focus on whether Q4 trends persist and on the timing/confirmation of the upcoming earnings report.
Background
The article frames QXO’s recent pre-announced Q3 results and ongoing Q4 trends, then summarizes Raymond James’ valuation approach and reiterated rating.
Ticker impact
Raymond James reiterated an Outperform rating and $21 price target after QXO’s Q3 EBITDA beat and encouraging Q4 trends to date.
Likely modest upward bias as the market weighs the reiterated Outperform call and the $21 target against the current ~$12.60 price.
The article is an analyst reiteration tied to specific operating takeaways (Q3 EBITDA beat, Q4 trends) and a detailed valuation narrative, but it is not a fresh company disclosure.
Market effects
Limited sector read-through; this is primarily single-name valuation and earnings-trend framing.
None indicated.
None indicated.
Counterpoint
Other banks cited in the article cut price targets (Truist to $15 from $26) due to rising operating costs and weak market conditions, suggesting upside may be capped if margins deteriorate.
Key entities
- companyQXO Inc
NASDAQ-listed company discussed as having a Q3 EBITDA beat and encouraging Q4 trends, with analyst valuation debate around growth and margins.
- analyst_firmRaymond James
Reiterated Outperform rating and $21 price target for QXO, citing Q3 EBITDA beat and valuation framework.
- analyst_firmDA Davidson
Adjusted price target to $19 from $20 while maintaining Buy rating, per the article.
- analyst_firmTruist Securities
Reduced price target to $15 from $26 while maintaining Buy rating, per the article.

